A detailed history of Checchi Capital Advisers, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Checchi Capital Advisers, LLC holds 22,615 shares of ABBV stock, worth $4.42 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
22,615
Previous 22,651 0.16%
Holding current value
$4.42 Million
Previous $4.12 Million 5.97%
% of portfolio
0.2%
Previous 0.22%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

SELL
$154.79 - $180.76 $5,572 - $6,507
-36 Reduced 0.16%
22,615 $3.88 Million
Q1 2024

Apr 25, 2024

BUY
$159.82 - $182.1 $21,575 - $24,583
135 Added 0.6%
22,651 $4.12 Million
Q4 2023

Feb 07, 2024

SELL
$137.6 - $154.97 $96,732 - $108,943
-703 Reduced 3.03%
22,516 $3.49 Million
Q3 2023

Nov 09, 2023

BUY
$133.59 - $154.65 $39,275 - $45,467
294 Added 1.28%
23,219 $3.46 Million
Q2 2023

Aug 09, 2023

SELL
$132.51 - $164.9 $73,940 - $92,014
-558 Reduced 2.38%
22,925 $3.09 Million
Q1 2023

May 05, 2023

BUY
$144.61 - $166.54 $76,787 - $88,432
531 Added 2.31%
23,483 $3.74 Million
Q4 2022

Feb 10, 2023

SELL
$138.31 - $165.87 $198,474 - $238,023
-1,435 Reduced 5.88%
22,952 $3.71 Million
Q3 2022

Nov 09, 2022

BUY
$134.21 - $153.93 $37,847 - $43,408
282 Added 1.17%
24,387 $3.27 Million
Q2 2022

Aug 11, 2022

BUY
$137.62 - $174.96 $413,548 - $525,754
3,005 Added 14.24%
24,105 $3.46 Million
Q1 2022

May 09, 2022

BUY
$131.98 - $163.75 $320,051 - $397,093
2,425 Added 12.99%
21,100 $3.42 Million
Q4 2021

Feb 09, 2022

BUY
$107.43 - $135.93 $26,535 - $33,574
247 Added 1.34%
18,675 $2.53 Million
Q3 2021

Nov 09, 2021

SELL
$106.4 - $120.78 $47,454 - $53,867
-446 Reduced 2.36%
18,428 $1.99 Million
Q2 2021

Aug 06, 2021

SELL
$105.21 - $117.21 $24,198 - $26,958
-230 Reduced 1.2%
18,874 $2.13 Million
Q1 2021

May 10, 2021

SELL
$102.3 - $112.62 $67,415 - $74,216
-659 Reduced 3.33%
19,104 $2.07 Million
Q4 2020

Feb 12, 2021

SELL
$80.49 - $108.67 $207,583 - $280,259
-2,579 Reduced 11.54%
19,763 $2.12 Million
Q3 2020

Nov 10, 2020

SELL
$85.91 - $100.83 $190,290 - $223,338
-2,215 Reduced 9.02%
22,342 $1.96 Million
Q2 2020

Aug 12, 2020

BUY
$73.37 - $98.18 $206,463 - $276,278
2,814 Added 12.94%
24,557 $2.41 Million
Q1 2020

May 07, 2020

BUY
$64.5 - $97.79 $66,628 - $101,017
1,033 Added 4.99%
21,743 $1.66 Million
Q4 2019

Feb 07, 2020

BUY
$72.13 - $90.25 $251,300 - $314,431
3,484 Added 20.23%
20,710 $1.83 Million
Q2 2019

Aug 06, 2019

BUY
$65.7 - $83.98 $105,514 - $134,871
1,606 Added 10.28%
17,226 $1.25 Million
Q1 2019

May 09, 2019

SELL
$77.14 - $90.79 $97,273 - $114,486
-1,261 Reduced 7.47%
15,620 $1.26 Million
Q4 2018

Feb 07, 2019

SELL
$77.85 - $96.01 $199,062 - $245,497
-2,557 Reduced 13.15%
16,881 $1.56 Million
Q3 2018

Oct 29, 2018

BUY
$88.91 - $98.84 $24,539 - $27,279
276 Added 1.44%
19,438 $1.84 Million
Q2 2018

Aug 06, 2018

BUY
$89.78 - $106.23 $36,091 - $42,704
402 Added 2.14%
19,162 $1.78 Million
Q1 2018

May 01, 2018

BUY
$92.01 - $123.21 $20,426 - $27,352
222 Added 1.2%
18,760 $1.78 Million
Q4 2017

Feb 02, 2018

BUY
$89.56 - $98.21 $253,275 - $277,737
2,828 Added 18.0%
18,538 $1.79 Million
Q3 2017

Nov 02, 2017

BUY
$69.85 - $89.22 $1.1 Million - $1.4 Million
15,710
15,710 $1.4 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $345B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Checchi Capital Advisers, LLC Portfolio

Follow Checchi Capital Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Checchi Capital Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Checchi Capital Advisers, LLC with notifications on news.